Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT02831179Phase 1Withdrawn
Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor
Functional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Multiple Endocrine Neoplasia Type 2aMultiple Endocrine Neoplasia Type 2b

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Renuka Iyer

Roswell Park Cancer Institute

Related
7 trials

Shared therapeutic areas:

Metastatic Carcinoid TumorNeuroendocrine Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

LEBBE Céleste

AP-HP- Saint Louis

Related
1 trials

Shared therapeutic areas:

Carcinoma, Merkel Cell
Similarity Score1%

Francois Benard, MD

BC Cancer

Related
7 trials

Shared therapeutic areas:

Carcinoma, Merkel Cell
Similarity Score1%

GUILLOT Bernard

University Hospital, Montpellier

Related
1 trials

Shared therapeutic areas:

Carcinoma, Merkel Cell
Similarity Score1%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Carcinoma, Merkel Cell
Similarity Score1%

DRENO Brigitte

Nantes University Hospital

Related
1 trials

Shared therapeutic areas:

Carcinoma, Merkel Cell
Similarity Score1%

Heidi H Kong, M.D.

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Related
5 trials

Shared therapeutic areas:

Carcinoma, Merkel Cell
Similarity Score1%

Maryam Rahman, MD

University of Florida

Related
4 trials

Shared therapeutic areas:

Carcinoma, Merkel Cell

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Dan Zandberg, MD

UPMC Hillman Cancer Center

Related
6 trials

Shared therapeutic areas:

Carcinoma, Merkel Cell
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02831179Phase 1PrincipalInvestigator

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Functional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more
Withdrawn

All 1 trials loaded